[Federal Register Volume 83, Number 68 (Monday, April 9, 2018)]
[Notices]
[Pages 15175-15176]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07167]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: United States

ACTION:  Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before May 9, 2018. Such 
persons may also file a written request for a hearing on the 
application on or before May 9, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been delegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on March 
1, 2018, United States Pharmacopeial Convention, 12601 Twinbrook 
Parkway, Rockville, MD, 20852 applied to be registered as an importer 
of the following basic classes of controlled substances:

------------------------------------------------------------------------
           Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Cathinone................................            1235  I
Methaqualone.............................            2565  I
Lysergic acid diethylamide...............            7315  I
4-Methyl-2,5-dimethoxyamphetamine........            7395  I
4-Methoxyamphetamine.....................            7411  I
Codeine-N-oxide..........................            9053  I
Difenoxin................................            9168  I
Heroin...................................            9200  I
Morphine-N-oxide.........................            9307  I
Norlevorphanol...........................            9634  I
Methamphetamine..........................            1105  II
Phenmetrazine............................            1631  II
Methylphenidate..........................            1724  II
Amobarbital..............................            2125  II
Pentobarbital............................            2270  II
Secobarbital.............................            2315  II
Glutethimide.............................            2550  II
Phencyclidine............................            7471  II
Phenylacetone............................            8501  II
Alphaprodine.............................            9010  II
Anileridine..............................            9020  II
Cocaine..................................            9041  II

[[Page 15176]]

 
Dihydrocodeine...........................            9120  II
Diphenoxylate............................            9170  II
Levomethorphan...........................            9210  II
Levorphanol..............................            9220  II
Meperidine...............................            9230  II
Dextropropoxyphene, bulk (non-dosage                 9273  II
 forms).
Thebaine.................................            9333  II
Noroxymorphone...........................            9668  II
Alfentanil...............................            9737  II
Sufentanil...............................            9740  II
------------------------------------------------------------------------

    The company plans to import the bulk controlled substances for 
distribution of analytical reference standards to its customers for 
research and analytical purposes.

    Dated: April 2, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-07167 Filed 4-6-18; 8:45 am]
 BILLING CODE 4410-09-P